Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials.
about
Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.
P2860
Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Is there a higher risk of CNS ...... om randomized clinical trials.
@en
type
label
Is there a higher risk of CNS ...... om randomized clinical trials.
@en
prefLabel
Is there a higher risk of CNS ...... om randomized clinical trials.
@en
P2860
P356
P1433
P1476
Is there a higher risk of CNS ...... rom randomized clinical trials
@en
P2093
Andrew Hill
Christiane Moecklinghoff
P2860
P356
10.1310/HCT1503-79
P577
2014-05-01T00:00:00Z